AGFS yields 66.67% · PFE yields 6.13%● Live data
📍 AGFS pulled ahead of the other in Year 1
Combined, AGFS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AGFS + PFE for your $10,000?
AgroFresh Solutions, Inc. provides science-based solutions, data-driven technologies, and high-touch customer services. The company's flagship product is the SmartFresh system that regulates the post-harvest ripening effects of ethylene to preserve the texture, firmness, taste, and appearance of produce during storage, transportation, and retail display. It also provides Harvista technology for use in near-harvest management of apples, pears, cherries, and blueberries; FreshCloud, a digital technology service platform of produce monitoring and screening solutions; and LandSpring, a 1- methlycycloproprene technology targeted to transplanted vegetable seedlings. In addition, the company offers fungicides, disinfectants, coatings, and packinghouse equipment for the citrus market under the Actiseal, FreshStart, VitaFresh Botanicals, Teycer Originals, and Control-Tec brands. It supports growers, packers, and retailers with solutions across the food supply chain to enhance the shelf life of fresh produce. The company primarily operates in the United States, Canada, Argentina, Brazil, Chile, Columbia, Costa Rica, the Dominican Republic, Ecuador, Guatemala, Mexico, Peru, Uruguay, Europe, the Middle East, Africa, Australia, China, India, Japan, New Zealand, South Korea, and the Philippines. AgroFresh Solutions, Inc. was founded in 1994 and is headquartered in Philadelphia, Pennsylvania.
Full AGFS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.